130 related articles for article (PubMed ID: 18410083)
1. Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.
Grace CR; Erchegyi J; Samant M; Cescato R; Piccand V; Riek R; Reubi JC; Rivier JE
J Med Chem; 2008 May; 51(9):2676-81. PubMed ID: 18410083
[TBL] [Abstract][Full Text] [Related]
2. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
[TBL] [Abstract][Full Text] [Related]
3. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212
[TBL] [Abstract][Full Text] [Related]
4. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
Nunn C; Langenegger D; Hurth K; Schmidt K; Fehlmann D; Hoyer D
Eur J Pharmacol; 2003 Apr; 465(3):211-8. PubMed ID: 12681432
[TBL] [Abstract][Full Text] [Related]
5. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
6. Ring size of somatostatin analogues (ODT-8) modulates receptor selectivity and binding affinity.
Erchegyi J; Grace CR; Samant M; Cescato R; Piccand V; Riek R; Reubi JC; Rivier JE
J Med Chem; 2008 May; 51(9):2668-75. PubMed ID: 18410084
[TBL] [Abstract][Full Text] [Related]
7. Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).
Rivier JE; Hoeger C; Erchegyi J; Gulyas J; DeBoard R; Craig AG; Koerber SC; Wenger S; Waser B; Schaer JC; Reubi JC
J Med Chem; 2001 Jun; 44(13):2238-46. PubMed ID: 11405660
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.
Ginj M; Zhang H; Waser B; Cescato R; Wild D; Wang X; Erchegyi J; Rivier J; Mäcke HR; Reubi JC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16436-41. PubMed ID: 17056720
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan.
Erchegyi J; Hoeger CA; Low W; Hoyer D; Waser B; Eltschinger V; Schaer JC; Cescato R; Reubi JC; Rivier JE
J Med Chem; 2005 Jan; 48(2):507-14. PubMed ID: 15658864
[TBL] [Abstract][Full Text] [Related]
10. N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and function.
Erchegyi J; Cescato R; Waser B; Rivier JE; Reubi JC
J Med Chem; 2011 Sep; 54(17):5981-7. PubMed ID: 21806016
[TBL] [Abstract][Full Text] [Related]
11. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
[TBL] [Abstract][Full Text] [Related]
12. N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity.
Rajeswaran WG; Hocart SJ; Murphy WA; Taylor JE; Coy DH
J Med Chem; 2001 Apr; 44(9):1416-21. PubMed ID: 11311064
[TBL] [Abstract][Full Text] [Related]
13. Highly potent cyclic disulfide antagonists of somatostatin.
Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
[TBL] [Abstract][Full Text] [Related]
14. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.
Rajeswaran WG; Hocart SJ; Murphy WA; Taylor JE; Coy DH
J Med Chem; 2001 Apr; 44(8):1305-11. PubMed ID: 11312929
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting.
Cescato R; Erchegyi J; Waser B; Piccand V; Maecke HR; Rivier JE; Reubi JC
J Med Chem; 2008 Jul; 51(13):4030-7. PubMed ID: 18543899
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.
Feuerbach D; Fehlmann D; Nunn C; Siehler S; Langenegger D; Bouhelal R; Seuwen K; Hoyer D
Neuropharmacology; 2000 Jun; 39(8):1451-62. PubMed ID: 10818261
[TBL] [Abstract][Full Text] [Related]
18. Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors.
Di Cianni A; Carotenuto A; Brancaccio D; Novellino E; Reubi JC; Beetschen K; Papini AM; Ginanneschi M
J Med Chem; 2010 Aug; 53(16):6188-97. PubMed ID: 20666484
[TBL] [Abstract][Full Text] [Related]
19. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806.
Nunn C; Schoeffter P; Langenegger D; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):1-9. PubMed ID: 12616335
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.
Grace CR; Erchegyi J; Reubi JC; Rivier JE; Riek R
Biopolymers; 2008 Dec; 89(12):1077-87. PubMed ID: 18655144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
